Next time you receive grief re legitimacy of PEMF tell the

New Post Public Reply Private Reply Replies (1) Message Board
swordfish
440
Next time you receive grief re legitimacy of PEMF tell the NASA story

NASA’S EXPLORATION OF MAGNETIC THERAPY A SUCCESS

NASA has invest $3.5 million into four years of magnetic therapy studies

You know the National Aeronautics and Space Administration (NASA) as the American agency responsible for putting a man on the moon, conducting 135 Space Shuttle missions between 1981 and 2011, and generally advancing aeronautics and aerospace research. What you may find surprising is that NASA has also concluded a number of studies on magnetic therapy, which is officially known as pulsed electromagnetic field therapy (PEMF).

What did NASA’s studies conclude? Magnetic therapy is effective in healing refractory broken bones — bones that are unable to heal despite repeated surgical procedures. NASA also found magnetic therapy is successful in developing tissues for transplantation, repairing traumatized tissues, and moderating some neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Lastly, previous studies also suggest that PEMF might be useful in the treatment of some muscle disorders.

In 2009, NASA was awarded the U.S. patent for PEMF use to enhance tissue repair in mammals, and to reverse the bone loss experienced by astronauts when they are in a gravity-free environment and away from the earth’s magnetic field. NASA scientists’ ultimate goal for magnetic therapy is to create an astronaut suit that would provide a countermeasure for the muscle atrophy and bone loss associated with space flight. NASA’s findings in regards to magnetic therapy to sustain astronauts’ well-being while in space have been instrumental in validating ongoing scientific studies and the development of PEMF devices.

Clearly, magnetic therapy doesn’t just benefit astronauts. As NASA research concluded: On earth, this device is effective in the treatment of various muscle diseases, age- and cancer-related muscle atrophy, osteoporosis and other bone diseases. Currently, the Food and Drug Administration has cleared magnetic therapy for fusing broken bones, treating severe untreatable depression, and post-operative pain and swelling.

https://www.facebook.com/biomagnetism.ie/phot...018788852/


Deeper dive for the scientific minded.

Electromagnetic Fields to Sustain Life on Earth, in Space, and Planets

Earth's geomagnetic field or natural pulsed electromagnetic frequencies (PEMFs) are essential to sustain the health of humans and life. As organisms have evolved within Earth's magnetic field .2-.7 Gauss (20-70µT) and electric field (100-300 V/min) for billions of years, PEMFs have an important role in sustaining life beyond Earth and for human space exploration. In the early 2000s, NASA demonstrated that astronauts who are cut off from Earth's magnetic field developed health problems, which could be mitigated by generating an artificial magnetic field.

The impact of a pulsed electromagnetic fields(PEMFs) on a biological organism varies based on the intensity, timing, and application. Both natural and artificial electromagnetic fields can enhance cell function, develop tissues for transplantation, repair traumatized tissues, and moderate some neurological conditions. Several clinical studies demonstrated that PEMFs influence cell activity, the autonomic nervous system and the blood flow. Studies on the short-term effects of a PEMF therapy (0.005, 0.03 and 0.09 T/s)demonstrate that the therapeutic application of pulsed electromagnetic fields can accelerate healing after bone fractures and also alleviate pain.

https://www.researchgate.net/publication/3564...nd_Planets


BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Nippon Steel and TIER IV Unite for Autonomous Steel Transport

Updated Category News Views 357

Innovative Partnership for Autonomous Steel Transportation Nippon Steel Corporation, known as Japan's largest steel manufacturer, has initiated a significant collaboration with TIER IV, Inc., a trailblazer in the development of open-source software for autonomous driving. This partnership is set to revolutionize the way steel is transported within manufacturing...

Continue Reading
Brock Group Expands Leadership with New Regional Units

Updated Category News Views 303

The Brock Group Expands Leadership with New Regional Units The Brock Group is taking significant strides in enhancing its Brock Industrial Services (BIS) division. Recently, the company announced the creation of two new regional operating units designed to bolster its service capabilities and responsiveness for customers nationwide. Under this new organizational...

Continue Reading
Exploring Demand for Nasdaq-100 Index in Retirement Plans

Updated Category News Views 178

Rising Interest in Nasdaq-100 Index for Retirement Investments Recent findings reveal a burgeoning interest in the Nasdaq-100 Index among retirement plan participants. This trend signifies a noteworthy opportunity for retirement investment options catering to the needs of a modern workforce. A recent survey indicated that nearly 80 percent of 401(k) plan participants...

Continue Reading
ModivCare Securities Lawsuit Update: Key Details for Investors

Updated Category News Views 132

Important Updates Regarding ModivCare Lawsuit Levi & Korsinsky, LLP is reaching out to investors who have been part of ModivCare Inc. (NASDAQ: MODV) regarding a pivotal class action securities lawsuit. This notification signals a chance for investors affected by the Company’s alleged securities fraud to seek compensation. Understanding the Class Action Lawsuit The...

Continue Reading
Key Details for Nordic Fibreboard AS Annual Meeting Announcement

Updated Category News Views 163

Essential Details for the Upcoming Annual General Meeting The Annual General Meeting (AGM) of Nordic Fibreboard AS (registry code: 11421437) will be convened to discuss pivotal matters affecting the company's future. Set to take place at the headquarters in Pärnu, Estonia, the AGM is a prime opportunity for shareholders to engage directly with the company's management...

Continue Reading